Sabrina Annick Assoumou, MD, MPH

Assistant Professor, Medicine

Sabrina Assoumou

Biography

Sabrina A. Assoumou, MD MPH, is Assistant Professor of Medicine at Boston University School of Medicine and an attending physician in the section of Infectious Diseases at Boston Medical Center. She is a clinician-investigator who cares for human immunodeficiency virus (HIV)-infected patients at the BUSM/BMC’s Centers for Infectious Diseases. Her research focuses on medical complications of substance use including HIV and Hepatitis C virus (HCV). She is also interested in models of care and on improving the continuum of care for individuals with HIV and/or HCV. She is currently the Principal Investigator on an NIH K23 Mentored Career Development Award to improve linkage to care after testing for HIV and HCV at a drug detoxification center.

Dr. Assoumou graduated magna cum laude from Williams College and obtained her medical degree from the University of Rochester School of Medicine and Dentistry. She then completed a combined Internal Medicine/Pediatrics residency at Brown University and an Infectious Diseases Fellowship at Harvard University’s Beth Israel Deaconess Medical Center where she was awarded the Finland Award for Research Excellence. She also earned a Masters of Public Health at the Harvard T.H. Chan School of Public Health.

Education

  • University of Rochester School of Medicine & Dentistry, MD
  • Harvard School of Public Health, MPH
  • Williams College, BA

Publications

  • Published on 5/16/2019

    Assoumou SA, Tasillo A, Vellozzi C, Yazdi GE, Wang J, Nolen S, Hagan L, Thompson W, Randall LM, Strick L, Salomon JA, Linas BP. Cost-effectiveness and budgetary impact of HCV testing, treatment and linkage to care in U.S. prisons. Clin Infect Dis. 2019 May 16. PMID: 31095676.

    Read at: PubMed
  • Published on 2/11/2019

    Childs E, Assoumou SA, Biello KB, Biancarelli DL, Drainoni ML, Edeza A, Salhaney P, Mimiaga MJ, Bazzi AR. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs. Harm Reduct J. 2019 Feb 11; 16(1):14. PMID: 30744628.

    Read at: PubMed
  • Published on 11/19/2018

    Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016. Am J Prev Med. 2019 Jan; 56(1):8-16. PMID: 30467088.

    Read at: PubMed
  • Published on 1/18/2018

    Assoumou SA, Tasillo A, Leff JA, Schackman BR, Drainoni ML, Horsburgh CR, Barry MA, Regis C, Kim AY, Marshall A, Saxena S, Smith PC, Linas BP. Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings. Clin Infect Dis. 2018 Jan 18; 66(3):376-384. PMID: 29020317.

    Read at: PubMed
  • Published on 1/1/2017

    Assoumou SA, Huang W, Young K, Horsburgh CR, Linas BP. Real-world Outcomes of Hepatitis C Treatment during the Interferon-free Era at an Urban Safety-net Hospital. J Health Care Poor Underserved. 2017; 28(4):1333-1344. PMID: 29176099.

    Read at: PubMed
  • Published on 12/27/2016

    Linas BP, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1. Open Forum Infect Dis. 2017; 4(1):ofw266. PMID: 28480259.

    Read at: PubMed
  • Published on 11/17/2015

    Young KL, Huang W, Horsburgh CR, Linas BP, Assoumou SA. Eighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmission. J Viral Hepat. 2016 Apr; 23(4):274-81. PMID: 26572798.

    Read at: PubMed
  • Published on 3/31/2015

    Linas BP, Barter DM, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med. 2015 May 5; 162(9):619-29. PMID: 25820703.

    Read at: PubMed
  • Published on 5/19/2014

    Linas BP, Barter DM, Leff JA, Assoumou SA, Salomon JA, Weinstein MC, Kim AY, Schackman BR. The hepatitis C cascade of care: identifying priorities to improve clinical outcomes. PLoS One. 2014; 9(5):e97317. PMID: 24842841.

    Read at: PubMed
  • Published on 5/14/2014

    Assoumou SA, Huang W, Horsburgh CR, Drainoni ML, Linas BP. Relationship between hepatitis C clinical testing site and linkage to care. Open Forum Infect Dis. 2014 Mar; 1(1):ofu009. PMID: 25734083.

    Read at: PubMed

View 4 more publications: View full profile at BUMC

View all profiles